NHS FPX 8002 Assessment 1 Demonstrating Effective Leadership
Student Name
Capella University
NHS-FPX8002 Collaboration Communication, and Case Analysis for Doctoral Learners
Professor Name
Submission Date
Demonstrating Effective Leadership
Opioid addiction could be regarded as one of the most pressing problems related to chronic population health in the U.S., and affects the lives of thousands of individuals irrespective of their social, ethnic, and geographical backgrounds. Patients are not the only people who are impacted by the issue, but their relatives, hospitals, and communities as well (Dydyk et al., 2024). It is essential to solve such an interdisciplinary issue with the help of interprofessional leadership. In the paper, one of the leadership strategies that will be discussed is geared towards establishing a coalition that will combat opioid use disorders.
Contributing Factors
There are numerous factors in the opioid crisis, which could be divided into the historical, socioeconomic, medical, and environmental factors. The prescription opioid manufacturers had popularized them as safe painkillers to consumers in the late nineties. There was also a rise in the number of prescriptions, even though there was inadequate control over distribution, which was accompanied by promotion. The third wave of the opioid crisis began when people began to use illicit opioids like heroin and fentanyl after the shortage in the market or when they became costly (CDC, 2024). In terms of social determinants of health, the number of opioid addicts among the poor, illiterate, and underprivileged individuals is very high. The problem is also acute among the residents of rural and economically depressed localities where there is a high unemployment rate. There has been a decline in the manufacturing industry in some states in the past. This phenomenon resulted in despair, which was greatly related to the increased use of drugs and overdose deaths (Heffernan et al., 2025). Childhood experiences that are negative, especially neglect, violence, and family dysfunction, are some of the major causes of subsequent substance abuse.
The intricacy of the racial and ethnic disparity with regard to the epidemic adds to the complex nature. Although the disease started among the European American and non-Hispanic communities residing in rural communities, recent statistics have indicated that African Americans are currently reporting more deaths as a result of overdose because of the availability of fentanyl in the drugs and challenges of seeking treatment services (CDC, 2024). Another disadvantaged group is indigenous peoples, who are experiencing an upsurge in fatal overdoses as a result of historical traumas, geographical barriers, and insufficient funding for health care provision. The environmental aspect entails the inaccessibility of mental health care facilities, the absence of certified experts to assist in overcoming opioid addiction, and severe criminal punishments. There are concurrent mental disorders related to the use of opioids, particularly depression and anxiety disorders, which present further complications. At the financial level, the direct health care costs, lost productivity, criminal activities, and participation in various social programs make up the annual expenses of the opioid crisis in the US, estimated at over $1 trillion (Luo et al., 2020). Overall, all these factors make an alliance approach in combating the public health issue inevitable.
Coalition to Address the Population Health Topic Selected
There is a need to have an effective interprofessional coalition in order to effectively fight the epidemic of opioids. The coalition, described in the paper, consists of eight various organizations with knowledge (which is broad in many aspects) in numerous areas, including healthcare practice, population health, social work, police force, education, and community participation. The strategy made sure that every person selected is a major player in the area of opioid use disorder, which can aid in achieving the triple aim objectives. The following table is an outline of the members of the coalition team and their respective inputs towards the goals of the coalition.
-
Table 1
Coalition Team Members and Their Contribution
|
Coalition Team Members |
Contribution |
|
J. R., DNP, APRN-BC, Senior Nurse Practitioner and MAT Program Director, County Opioid Recovery Clinic |
Gives direct patient evaluations, offers medication-assisted therapy (MAT) including buprenorphine, and organizes care plans. Provides clinical skills in the management of withdrawal and comorbid mental health problems. |
|
M. T., MD, Addiction Psychiatrist and Dual-Diagnosis Program Chief, Regional Behavioral Health Authority |
Psychiatric assessment leads, prescribes, and manages pharmacotherapy, and facilitates evidence-based mental health interventions to co-occurring conditions prevalent among people with opioid use disorder. |
|
A. V., LCSW, Senior Case Manager, County Department of Human Services |
Psychosocial assessment, access to housing, food security, financial aid, and case management to cover social determinants of recovery outcomes. |
|
S. N., MPH, State Opioid Response Grant Manager, State Department of Health, Division of Substance Use Prevention |
Makes public health data available, coordinates policy, gets the state and federal grants, and makes sure that the activities of the coalition do not violate state opioid response frameworks. |
|
P. L., MEd, K-12 Substance Use Prevention Coordinator, Local Unified School District, Student Wellness Office |
Conducts prevention education among young people at school, recognizes at-risk young people, and mobilizes parents and teachers in early prevention and awareness activities. |
|
Rev. C. M. Faith Community Health Ambassador Interfaith Opioid Response Network |
Activates community support systems, eliminates stigma by communicating in religious institutions, and offers groups of recovery and community healing opportunities. |
Since the doctoral-prepared nurse practitioner will be the leader of the coalition, he/she will be the convener and facilitator of the organization so that all the members are in agreement with the organizational mission. This kind of leadership requires not only clinical knowledge but interprofessional communication, planning, and community organization skills as well. This engagement of the clinical and non-clinical members indicates that there is an understanding that the problem of opioid addiction cannot be addressed using solely medical practice but requires a comprehensive shift in the community.
Issues Affecting Collaboration
There are certain inherent challenges of the interaction in an interprofessional group that is heterogeneous. One of the most noticeable ones is the presence of professional silos since members of the coalition would be working along various disciplinary prisms, with different jargons, and organizational cultures. Within a healthcare setting, physicians may be more inclined to use the clinical and evidence-based decision-making perspective, whereas law enforcement agents may have a more public security or criminal deterrent approach to the issue, like opioid addiction (Ostrach et al., 2024). This could result in conflicts because of such differences in thinking.
The other issue of concern is the issue of power in the group. Doctors and managers might be involved in the process, unintentionally becoming leaders, thereby taking over the role of other coalition members, such as community health workers and faith leaders, who may have useful information to add to the discussion, depending on personal experiences and local knowledge. The scientific literature indicates that the understanding of hierarchy in healthcare groups has been revealed to restrict the psychological safety and communication (Lee and Lee, 2024). Lastly, the role ambiguity may interfere with the operations of the coalition. In this instance, there may be overlap and gaps in responsibility as there may not be clear roles among the coalition members. There might be an uncertainty of the roles that members should assume in the process (Roschk et al., 2023). Furthermore, the divergent missions, funding sources, and accountability needs can promote conflicting interests, which can hamper cooperation. The stakeholders in the coalition may also be concerned about the stigmatization of opioid addiction, particularly when some of the stakeholders in the coalition adopt a moralistic/punitive approach to substance abuse disorders.
Strategies to Optimize Collaboration
Planned steps will be necessary in leadership to make sure that there is cohesion and communication among the members. It is significant to have a vision and mission statement at the beginning (Jenkins et al., 2022). As soon as the members of the coalition come to an agreement regarding what they would like to achieve, their individual interests and concerns as a professional field will be put on the back burner. To establish an atmosphere of effective communication, it is essential that the leader of the coalition organizes a team-building activity either through virtual or face-to-face communication, where the members will become familiar with one another and reach a consensus on the standards, expectations, and rules of conduct.
The communication process needs to be efficient, and this can only be achieved by having structured communication guidelines. Meetings would be either in-person or online, and they would follow a standard agenda, which would ensure that all the members have equal participation. The communication model used in healthcare, situation, background, assessment, and recommendation (SBAR) model, can be modified to fit the requirements of a coalition meeting (Shrivastava et al., 2025). One more aspect that the leader of the coalition should undertake is to integrate the methods of conflict resolution that involve a mediation process and an anonymous feedback system that will ensure that interpersonal and interdisciplinary conflicts do not escalate. Through the transformational leadership technique, which emphasizes motivating employees by inspiring them, treating them on a case-by-case basis, and challenging their minds, the members of the coalition will be motivated and inspired to remain committed to the task at hand (Deng et al., 2022). Cross-training programs will enable coalition members to know more about each other, their duties, and challenges.
Ethical Considerations
As the opioid epidemic can be viewed through the lens of a coalition approach to its management, multiple ethical concerns can be raised. Regarding micro-ethics, autonomy, beneficence, non-maleficence, and justice concepts need to be taken into account (Olejarczyk & Young, 2024). The addict should be given a choice of either using medication-assisted treatment or behavioral therapies, as well as a harm reduction approach, such as the needle exchange program, as an opioid-dependent individual. Interacting with patients in the coalitions, all providers should not resort to coercion, stigmatization, and discrimination based on previous relapses and any other social attributes that may impact access to treatment.
At the meso level, the systemic organization of treatment has to be taken into account in relation to the ethical issues of the system. As it has been shown, it is very unequal and varies based on the paying capacity to have access to sufficient evidence-based treatment options for opioids (Pew, 2022). People who are uninsured, underinsured, those who live in rural areas, and racial/ethnic minorities are the groups of the population who lack access to proper treatment more than any other group. Thus, eliminating all the existing obstacles to treatment, i.e., prior authorization of the use of buprenorphine and restricted access to methadone, should be listed among the main tasks of the coalition.
There are also considerations of confidentiality and data privacy, which might also be an added ethical dilemma, as the information would be disseminated amongst coalition members in different fields. The federal laws (42 CFR Part 2) specify standards of confidentiality of substance use disorder treatment records (Winfield & Huffman, 2025). The regulations are even more stringent than the standard afforded by the Health Insurance Portability and Accountability Act (HIPAA), and the members of the coalition should be made aware of that. In addition, there will be certain codes of ethics that will be adhered to by each of the disciplines that the coalition will involve. In particular, the nurses will be expected to follow the American Nurses Association Code of Ethics, the social workers will be required to follow the National Association of Social Workers Code of Ethics, and the professionals working in the field of public health will have to follow the ethical principles of the American Public Health Association (ANA, 2025; National Association of Social Workers, 2021). Adherence to the codes of ethics is necessary to make the coalition a success.
Collaboration, Diversity, and Inclusion
Diversity, equity, and inclusion should be part of not only the composition of the group formed to address the issue of opioid addiction but also of the operations of the organization to design a coalition that will help resolve the issue. The coalition members are more diverse than just in terms of race and ethnicity. The strategy involves workers with different backgrounds in terms of industry and geographical location, experience in addressing opioid addiction, and those who represent the concerned communities. Diversity results in improved decision-making and creativity as research demonstrates (Elamin et al., 2024). The coalition needs to have a community health worker who has an opioid use disorder. Authentic cultural competency and legitimacy in its application by peer specialists can be offered in the work with the target populations, which is impossible to achieve by healthcare providers alone. Furthermore, their representation in the team implies that the initiative was developed taking care of people involved into consideration. The coalition leader is to establish a non-exclusive atmosphere; to do that, he/she must engage all people in the discussion and decision-making and avoid the use of too much jargon.
It is essential to engage the communities in an approach that is acceptable to them. The outreach efforts must be done in different languages, utilize culture-specific materials, and reach out to community-based institutions like places of worship, schools and colleges, and hair salons (Dadswell & Bungay, 2025). Cultural humility needs to be developed, which can be understood as a lifelong journey of self-reflection and open-mindedness towards learning, among all of the coalition members. Cultural humility is in stark demand where communities of color or Indigenous peoples, who were potentially exploited by the medical industry in the past, are concerned.
Literature Review to Address the Population Health Topic Selected
There is an existing strong evidence base that can be used to inform coalition-based interventions to address opioid use disorder, and scholar-practitioners have the responsibility to make sure that coalition approaches are based on up-to-date, peer-reviewed literature. Wakeman et al. (2023) used the results of over 40,000 patients with opioid use disorder in a large-scale comparative effectiveness trial to examine the effects of different interventions. The researchers have observed that the survival and abstinence rates among the patients who were administered either buprenorphine or methadone were significantly different compared to those of patients who were not administered any drug or had their behavioral interventions alone. To the extent the coalition is involved, the paper presents an explicit argument as to why MAT provision is essential as the foundation of evidence-based interventions and why the nurse practitioner and the psychiatrist should be involved in the administration of the medication.
In another article released in Addiction, Krawczyk et al. (2022) demonstrated that low-barrier models of buprenorphine delivery that were characterized by instant access, the least possible level of bureaucracy in the way of prior authorization, and peer support had more patients adherent to treatment over time, particularly among African American and Latino patients. The importance of the research paper to the equity-oriented goals of the coalition is based on the validation of the role of the peer recovery specialist and faith ambassador as intermediaries to care for the hitherto underserved groups. The two studies above, therefore, provide the coalition with a non-pharmacological and structural equity system of interventions that are based on existing evidence.
Conclusion
The issue of opioid addiction is one that will demand an immediate solution that will cross the borders of a single field or agency. The outlined leadership in the paper suggests the willingness to the evidence-based approach that is supported by ethical principles and inclusiveness. Consequently, the suggested coalition will be capable of addressing both the immediate demands of the situation and global problems related to the opioid issue by including clinicians, representatives of public health, community members, and social services. Leadership, in its turn, is an important part of such work.
Step-By-Step Instructions to write
NHS FPX 8002 Assessment 1
For step-by-step instructions on NHS FPX 8002 Assessment 1, visit nhsfpx8002assessment.com.
References for
NHS FPX 8002 Assessment 1
ANA. (2025). Code of ethics for nurses. American Nurses Association. https://codeofethics.ana.org/home
CDC. (2024, April 23). Understanding the opioid overdose epidemic. Overdose Prevention. https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html?CDC_AAref_Val=https://www.cdc.gov/opioids/basics/epidemic.html
Dadswell, A., & Bungay, H. (2025). Social prescribing of cultural opportunities to support health and wellbeing: The importance of language, community engagement, and inclusion in developing local approaches. BioMed Central Primary Care, 26(1), 149. https://doi.org/10.1186/s12875-025-02835-9
Deng, C., Gulseren, D., Isola, C., Grocutt, K., & Turner, N. (2022). Transformational leadership effectiveness: An evidence-based primer. Human Resource Development International, 26(5), 627–641. https://doi.org/10.1080/13678868.2022.2135938
Dydyk, A. M., Jain, N. K., & Gupta, M. (2024). Opioid use disorder. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK553166/
Elamin, A. M., Aldabbas, H., & Zain, A. (2024). The impact of diversity management on innovative work behavior: The mediating role of employee engagement in an emerging economy. Frontiers in Sociology, 9, e1441109. https://doi.org/10.3389/fsoc.2024.1441109
Heffernan, M., Papanikolaou, M., & Meit, M. (2025, September 23). Appalachian diseases of despair, 2025 – Appalachian regional commission. Appalachian Regional Commission. https://www.arc.gov/report/appalachian-diseases-of-despair-2025/
Jenkins, G., Cooper, B. R., Funaiole, A., & Hill, L. (2022). Which aspects of coalition functioning are key at different stages of coalition development? A qualitative comparative analysis. Implementation Research and Practice, 3. https://doi.org/10.1177/26334895221112694
Krawczyk, N., Rivera, B. D., Jent, V., Keyes, K. M., Jones, C. M., & Cerdá, M. (2022). Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019″. International Journal of Drug Policy, 110, e103786. https://doi.org/10.1016/j.drugpo.2022.103786
Lee, S. E., & Lee, J. W. (2024). Effects of hierarchical unit culture and power distance orientation on nurses’ silence behavior: The roles of perceived futility and hospital management support for patient safety. Journal of Nursing Management, 2024(1). https://doi.org/10.1155/jonm/6564570
Luo, F., Li, M., & Florence, C. (2021). State-Level economic costs of opioid use disorder and fatal opioid overdose — United States, 2017. Morbidity and Mortality Weekly Report, 70(15), 541–546. https://doi.org/10.15585/mmwr.mm7015a1
National Association of Social Workers. (2021). Code of ethics. National Association of Social Workers. https://www.socialworkers.org/About/Ethics/Code-of-Ethics/Code-of-Ethics-English
Olejarczyk, J., & Young, M. (2024). Patient rights and ethics. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK538279/
Ostrach, B., Hixon, V., & Bryce, A. (2024). “When people who use drugs can’t differentiate between medical care and cops, it’s a problem.” Compounding risks of law enforcement harassment & punitive healthcare policies. Health & Justice, 12(1). https://doi.org/10.1186/s40352-023-00256-3
Pew. (2022, March 16). Barriers limit access to medication for opioid use disorder in Philadelphia. Pew.org; The Pew Charitable Trusts. https://www.pew.org/en/research-and-analysis/reports/2022/03/barriers-limit-access-to-medication-for-opioid-use-disorder-in-philadelphia
Roschk, H., Hosseinpour, M., & Breitsohl, J. (2023). Coalitions and their negative consequences: An examination in service failure-recovery situations. Journal of Service Research, 26(4), 614–635. https://doi.org/10.1177/10946705231163884
Shrivastava, S. R., Chong, S. V., & Bobhate, P. S. (2025). Facilitating effective communication through the adoption of the SBAR tool in medical training. Journal of Education and Health Promotion, 14(1), 249. https://doi.org/10.4103/jehp.jehp_1213_24
Wakeman, S. E., Larochelle, M. R., Ameli, O., Chaisson, C. E., McPheeters, J. T., Crown, W. H., Azocar, F., & Sanghavi, D. M. (2020). Comparative effectiveness of different treatment pathways for opioid use disorder. Journal of the American Medical Association Network Open, 3(2), e1920622. https://doi.org/10.1001/jamanetworkopen.2019.20622
Winfield, C., & Huffman, J. (2025). Confidentiality in addiction treatment: Navigating 42 CFR part 2 within human services. Journal of Human Services, 44(2). https://doi.org/10.52678/001c.132049
Capella professors to choose from for NHS-FPX8002 Class
- Nicole Aclin, DNP, MNSc, RN, CNE.
- Angela Saathoff, DNP, RN.
(FAQs) related to
NHS FPX 8002 Assessment 1
Question 1: What is NHS FPX 8002 Assessment 1 about?
Answer 1: Interprofessional leadership demonstrating coalition building to address the opioid crisis.